newsfilter
← Latest News
GlobeNewswire·

Jasper Therapeutics Announces Further Expansion of Clinical Program in Chronic Spontaneous Urticaria

REDWOOD CITY, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting